<p>A) and B) Down regulation of CD24 in CD24 rich UM-SCC-10B and UM-SCC-15s leads to significant down regulation of critical pro-survival genes, standard error of mean (t-test, n = 3). C) Up regulation of CD24 in CD24 deficient UM-SCC-74B leads to significant up regulation of critical pro-survival genes, standard error of mean (t-test, n = 3). D) Graph of the number of orospheres formed by the CD24 knockdown variants of UM-SCC-10B and UM-SCC-15s before and after an IC-50 dose of cisplatin treatment, standard error of mean (t-test, n = 3). E) Graph of the number of orospheres formed by the CD24 overexpressing variants of UM-SCC-74B before and after an IC-50 dose of cisplatin treatment, standard error of mean (t-test, n = 3).</p
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...
Cancer cells utilise several mechanisms to increase their survival and progression as well as their ...
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...
Platinum-based therapy is the most often used chemotherapeutic agent to treat advanced cases of head...
Platinum-based therapy is the most often used chemotherapeutic agent to treat advanced cases of head...
CD24 is associated with unfavourable prognoses in various cancers, but the prevalence of CD24 expres...
<div><p>CD24 is associated with unfavourable prognoses in various cancers, but the prevalence of CD2...
Background and Aim: The cluster of differentiation 24 (CD24) is a human protein encoded by the CD24 ...
Background and Aim: The cluster of differentiation 24 (CD24) is a human protein encoded by the CD24 ...
Breast cancer (BC) is a leading cause of cancer-related death in women. Adjuvant systemic chemothera...
Many mechanisms of cisplatin resistance have been proposed from studies of cellular models of resist...
Ovarian cancer is the most lethal gynecologic cancer, with a mortality rate of > 60%. Cancer stem ce...
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is trea-ted with HER2-targete...
La caractérisation de cellules résistantes aux traitements à l’origine des récidives et rechutes est...
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...
Cancer cells utilise several mechanisms to increase their survival and progression as well as their ...
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...
Platinum-based therapy is the most often used chemotherapeutic agent to treat advanced cases of head...
Platinum-based therapy is the most often used chemotherapeutic agent to treat advanced cases of head...
CD24 is associated with unfavourable prognoses in various cancers, but the prevalence of CD24 expres...
<div><p>CD24 is associated with unfavourable prognoses in various cancers, but the prevalence of CD2...
Background and Aim: The cluster of differentiation 24 (CD24) is a human protein encoded by the CD24 ...
Background and Aim: The cluster of differentiation 24 (CD24) is a human protein encoded by the CD24 ...
Breast cancer (BC) is a leading cause of cancer-related death in women. Adjuvant systemic chemothera...
Many mechanisms of cisplatin resistance have been proposed from studies of cellular models of resist...
Ovarian cancer is the most lethal gynecologic cancer, with a mortality rate of > 60%. Cancer stem ce...
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is trea-ted with HER2-targete...
La caractérisation de cellules résistantes aux traitements à l’origine des récidives et rechutes est...
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...
Cancer cells utilise several mechanisms to increase their survival and progression as well as their ...
The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resi...